Dr. Jonathan Stein, MS, Ph.D., HCLD(ABB), is a seasoned leader in clinical laboratory science, research and development, and executive management, currently serving as the Laboratory Director at SpectraCell Laboratories in Houston, Texas. With a career spanning over two decades, he has held pivotal roles such as Chief Science Officer, Research Investigator and Medical Director at multiple prestigious organizations, including CNSide Diagnostics, MD Anderson Cancer Center and Gene By Gene/FamilyTreeDNA. At SpectraCell, Dr. Stein provides clinical and scientific leadership for advanced nutritional, lipid and molecular longevity testing. His expertise encompasses laboratory accreditation, novel assay R&D, next-generation sequencing (NGS), and high-throughput optimization, driving advancements in clinical testing for anti-aging, nutrition, endocrinology, and molecular diagnostics.
Previously, Dr. Stein spearheaded clinical oversight and scientific innovation across a network of laboratories. His extensive background includes molecular biology, genetics, and biostatistics, complemented by a robust academic foundation with a Ph.D. from the University of Texas Graduate School of Biomedical Sciences, postdoctoral research at M.D. Anderson Cancer Center, and board certification from the American Association of Bioanalysis. A prolific communicator, Dr. Stein has authored numerous publications and delivered presentations on topics ranging from pharmacogenomics to advanced cancer diagnostics, solidifying his reputation as a thought leader in the biomedical field.
